Mostrar el registro sencillo del ítem
dc.contributor.author
Peña, Juan Francisco
dc.contributor.author
Gallo, Loreana Carolina
dc.contributor.author
Cotabarren, Ivana María
dc.date.available
2025-12-04T14:49:50Z
dc.date.issued
2024
dc.identifier.citation
3D- Printing Capsular Devices for Compounding Pharmacy: Materials Characterization and Drug Stability Study; LVI Reunión Anual de la Asociación Argentina de Farmacología Experimental; Bahía Blanca; Argentina; 2024; 124-124
dc.identifier.isbn
978-631-90806-0-5
dc.identifier.uri
http://hdl.handle.net/11336/276882
dc.description.abstract
3D printing is revolutionizing the pharmaceutical industry by enabling personalized drug manufacturing with precise dosages and customized forms, facilitating controlled release profiles and innovative treatments. However, its implementation demands rigorous quality control to ensure safety and efficacy.In this context, magistral compounding combined with 3D printing, offers a promising approach to enhance the personalization of medications. This study aimed to physico-chemically characterize (i.e., FT-IR spectra, DSC thermograms and morphology) the materials used for the 3D printing of capsular devices (CDs), equivalent to size 0 hard gelatin capsules, with 0.4 and 0.9 mm wall thickness (CD-0-0.4 and CD-0-0.9). Losartan potassium, a common antihypertensive, was used as the model drug, and poly(vinyl alcohol) (PVA) was the printing filament. In addition, the stability of the drug inside the CDs was assessed under natural (25°C, 60% RH) and accelerated conditions (40°C, 75% RH) over 1 and 3 months. To this end, the FT-IR spectrum and DSC thermograms of the drug were analyzed and compared to initial values. The physicochemical characterization of the drug and PVA showed the chemical nature and morphology expected for those materials. Regarding drug stability inside CD-0-0.4, FT-IR spectrum and DSC thermogram confirmed no chemical changes in its chemical composition for natural (1 and 3 months) and accelerated conditions (1 month). Conversely, the CDs opened under 3 months accelerated conditions, preventing data acquisition.For CD-0-0.9, FT-IR and DSC confirmed no chemical changes in the drug chemical composition, only in natural conditions. In both accelerated conditions, the CDs opened. The difference in PVA mass between CD-0-0.4 and CD-0-0.9 allowed a higher water sorption that notably affected their structural integrity. In conclusion, CD-0-0.4 and CD-0-0.9 satisfactory preserve the stability of the drug in natural storage conditions.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Asociación Argentina de Farmacología Experimental
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
3D PRITING
dc.subject
CAPSULAR DEVICES
dc.subject
COMPOUNDING PHARMACY
dc.subject
STABILITY STUDY
dc.subject.classification
Otras Ingeniería de los Materiales
dc.subject.classification
Ingeniería de los Materiales
dc.subject.classification
INGENIERÍAS Y TECNOLOGÍAS
dc.title
3D- Printing Capsular Devices for Compounding Pharmacy: Materials Characterization and Drug Stability Study
dc.type
info:eu-repo/semantics/publishedVersion
dc.type
info:eu-repo/semantics/conferenceObject
dc.type
info:ar-repo/semantics/documento de conferencia
dc.date.updated
2025-10-07T11:45:12Z
dc.journal.pagination
124-124
dc.journal.pais
Argentina
dc.journal.ciudad
Bahía Blanca
dc.description.fil
Fil: Peña, Juan Francisco. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Química; Argentina
dc.description.fil
Fil: Gallo, Loreana Carolina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
dc.description.fil
Fil: Cotabarren, Ivana María. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Planta Piloto de Ingeniería Química. Universidad Nacional del Sur. Planta Piloto de Ingeniería Química; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Química; Argentina
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://aafeargentina.org/congreso-aafe-2024-2/
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.conicet.rol
Autor
dc.coverage
Nacional
dc.type.subtype
Congreso
dc.description.nombreEvento
LVI Reunión Anual de la Asociación Argentina de Farmacología Experimental
dc.date.evento
2024-10-23
dc.description.ciudadEvento
Bahía Blanca
dc.description.paisEvento
Argentina
dc.type.publicacion
Book
dc.description.institucionOrganizadora
Asociación Argentina de Farmacología Experimental
dc.description.institucionOrganizadora
Universidad Nacional del Sur
dc.source.libro
LVI Reunión Anual de la Asociación Argentina de Farmacología Experimental
dc.date.eventoHasta
2024-10-24
dc.type
Congreso
Archivos asociados